虚拟现实疗法对超声引导区域麻醉下手部手术患者疼痛感受的影响:随机对照试验
该前瞻性随机对照优效性试验纳入120例择期手部手术患者,比较围术期虚拟现实疗法(n=60)与无虚拟现实疗法(n=60)在区域麻醉置管和手术过程中的效果。主要结局超声引导区域麻醉置管期间平均疼痛评分两组差异无统计学意义(3.6±2.4 vs 3.9±2.4,平均差-0.3,95%CI -1.2至0.5,p=0.22)。虚拟现实疗法对围术期焦虑有显著正向影响,尤其手术期间焦虑评分显著降低(p<0.01),但疼痛评分未降低。
要点
- 虚拟现实疗法未降低超声引导区域麻醉置管期间的疼痛评分。
- 虚拟现实疗法显著改善手术期间的焦虑评分(p<0.01)。
- 虚拟现实疗法的不良反应发生率为11.9%(7例)。
核心结论
- 在超声引导区域麻醉置管和手部手术期间使用虚拟现实疗法未导致更低的疼痛评分。
- 虚拟现实疗法对围术期焦虑有显著正向影响,并具有临床意义。
研究设计与样本
- 前瞻性随机对照优效性试验,纳入120例择期手部手术患者。
- 患者随机分为虚拟现实疗法组(n=60)和无虚拟现实疗法组(n=60),在区域麻醉置管和手术过程中干预。
- 虚拟现实疗法为视觉和听觉三维被动程序。
主要发现
- 超声引导区域麻醉置管期间平均疼痛评分:对照组3.9±2.4,虚拟现实组3.6±2.4,平均差-0.3(95%CI -1.2至0.5;p=0.22)。
- 手术期间焦虑评分:对照组1.5(0.0, 4.0),虚拟现实组0.0(0.0, 2.0),p<0.01。
- 虚拟现实沉浸感总分平均4.2±0.9。
- 7例患者(11.9%)出现虚拟现实相关不良反应。
- 手术期间患者满意度和围术期阿片类药物使用无显著差异;虚拟现实满意度高:9.0(8.0, 10.0)。
关键数值与推荐
- 主要结局为超声引导区域麻醉置管期间平均疼痛评分(11点数字评定量表)。
- 焦虑采用11点数字评定量表(0=完全不焦虑,10=极度焦虑)。
- 患者满意度采用11点数字评定量表(0=完全不满意,10=极度满意)。
临床怎么用
- 虚拟现实疗法可作为围术期焦虑管理的辅助手段,尤其适用于手术期间焦虑较高的患者。
- 不应期望虚拟现实疗法能显著降低区域麻醉置管期间的疼痛评分。
- 需注意虚拟现实相关不良反应(本研究中发生率11.9%)。
局限性
- 不同虚拟现实系统的临床影响需在其他择期手术中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: During ultrasound-guided regional anesthesia and surgery, patients receive sensory input, which combined with stress and anxiety, can exacerbate or cause pain. Virtual reality therapy could provide digital sedation. Our aim is to assess the effect of virtual reality therapy on pain levels during the placement of regional anesthesia and surgery. METHODS: This prospective randomized controlled superiority trial enrolled 120 patients undergoing elective hand surgery to investigate the effect of perioperative virtual reality therapy, consisting of a visual and audible three-dimensional, passive program. Patients were randomized to virtual reality therapy (n=60) or no virtual reality therapy (n=60) during regional anesthesia block placement and surgical procedure. Mean pain score (11-point numerical rating scale) during ultrasound-guided regional anesthesia placement was the primary outcome. Secondary outcomes were the mean pain score during surgery, heart rate variation during ultrasound-guided regional anesthesia placement and surgery, perioperative opioid use, anxiety (11-point numerical rating scale where 0=no anxiety at all and 10=extremely anxious), virtual reality immersion and presence (Igroup Presence Questionnaire), adverse events and patient satisfaction (11-point numerical rating scale where 0=not satisfied at all and 10=extremely satisfied). RESULTS: Mean pain scores during ultrasound-guided regional anesthesia placement were 3.9±2.4 in the control group and 3.6±2.4 in the virtual reality group, with a mean difference of -0.3 (95% CI -1.2 to 0.5; p=0.22). Heart rate variation during ultrasound-guided regional anesthesia placement and surgery was non-significantly different. Anxiety during ultrasound-guided regional anesthesia placement showed no significant difference; however, it was significantly different during surgery (control: 1.5 (0.0, 4.0) vs virtual reality: 0.0 (0.0, 2.0), p<0.01). Virtual reality immersion showed a total mean score of 4.2±0.9. Seven patients (11.9%) suffered from adverse virtual reality effects. Patient satisfaction during surgery and perioperative opioid use showed no significant difference. Satisfaction with virtual reality was high: 9.0 (8.0, 10.0). CONCLUSION: Our results show that the use of virtual reality therapy during ultrasound-guided regional anesthesia placement and hand surgery does not result in lower pain scores. A perioperative significant positive effect on anxiety was measured, combined with a clinically significant effect on perioperative anxiety. The clinical influence of different virtual reality therapy systems on pain and anxiety should be further investigated in (other) elective procedures. TRIAL REGISTRATION NUMBER: NCT05183412.
引用
- Nijs K, Treunen T, Jalil H, et al. Effect of virtual reality (VR) therapy on pain sensation in patients undergoing hand surgery under ultrasound-guided regional anesthesia: a randomized controlled trial. Reg Anesth Pain Med. 2025. PMID: 40451290. doi:10.1136/rapm-2025-106418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。